
With healthcare trends shifting towards more outpatient procedures and the influx of the need for telemedicine following the Covid-19 pandemic, the healthcare market is primed and eager for the next wave of remote patient monitoring products. As a growing number of surgeries are being moved to outpatient facilities and hospital recovery times are decreasing to increase turnover, the need for remote patient monitoring technologies is continually expanding, and the emergence of new biometric capabilities in household devices introduces a data set that can be utilized to more quickly and accurately detect life altering complications, allowing patients to receive much needed interventions sooner and making this market ripe for disruption.
While most patient monitoring systems on the market focus on chronic disease management, our application of biometric capabilities and predictive analysis offers a competitive advantage, in that our system is one of the first on the market focused on the detection of acute health problems that are currently overlooked until it is too late. Instead of focusing only on disease management, our system can be applied to monitor patients for a number of different common post surgical complications, like embolism and thrombosis, allowing for earlier intervention and treatment. Without our product, patients have no choice but to wait for their complication to advance to a level where they risk permanent damage to their health or even death.
We have currently raised enough money to create the first iteration of our app platform, so our next step will be recruiting patients and hospital systems to conduct beta testing of our product. This funding will be pivotal in our growth because it will allow us to market our product to local healthcare networks for key opinion leader testing and to gain participants and recognition for our beta testing and product. Additionally, this funding will be used to purchase the secure data servers necessary to house our collected patient data.